2018 Disease Immune Response Targeted Protein Degradation 
Drug Discovery World
MAY 30, 2023
These targeted cytokines are selectively removed with the intention of neutralising the cancer’s ability to block a patient’s natural immune defence mechanisms, which are significantly compromised in late-stage, metastatic disease. This potentially re-energises the immune system to fight cancers.”
Drug Target Review
OCTOBER 4, 2023
Antibody-drug conjugates (ADCs) have been a groundbreaking approach to cancer treatment with their ability to deliver cytotoxic drugs directly to diseased cells while sparing healthy tissues. This targeted delivery allows enhanced therapeutic efficacy while reducing the harmful side effects commonly associated with traditional chemotherapy.
Expert insights. Personalized for you.
130 
Let's personalize your content